| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Seema Varma, Delia Bishara, Frank M C Besag, David Taylo. Clozapine-related EEG changes and seizures: dose and plasma-level relationships. Therapeutic advances in psychopharmacology. vol 1. issue 2. 2013-08-28. PMID:23983927. |
clozapine is a widely used atypical antipsychotic with a unique effectiveness in treatment-resistant schizophrenia. |
2013-08-28 |
2023-08-12 |
Not clear |
| Stephen Bleakley, David Brown, David Taylo. Does clozapine cause or worsen obsessive compulsive symptoms? An analysis and literature review. Therapeutic advances in psychopharmacology. vol 1. issue 6. 2013-08-28. PMID:23983945. |
clozapine is the most effective antipsychotic in treatment-resistant schizophrenia but its use portends with a high burden of adverse reactions. |
2013-08-28 |
2023-08-12 |
Not clear |
| Poornima Chandrappa, Luk H. Case reports of patients with treatment-resistant schizophrenia and related psychotic disorders intolerant to clozapine responding to high doses of quetiapine. Therapeutic advances in psychopharmacology. vol 2. issue 5. 2013-08-28. PMID:23983977. |
case reports of patients with treatment-resistant schizophrenia and related psychotic disorders intolerant to clozapine responding to high doses of quetiapine. |
2013-08-28 |
2023-08-12 |
Not clear |
| Vyasa Immadisetty, Pradeep Agrawa. A successful treatment strategy for clozapine-induced parotid swelling: a clinical case and systematic review. Therapeutic advances in psychopharmacology. vol 2. issue 6. 2013-08-28. PMID:23983982. |
a 58-year-old man treated with clozapine for treatment-resistant schizophrenia developed bilateral painful parotid swellings and hypersalivation. |
2013-08-28 |
2023-08-12 |
Not clear |
| John Lally, Colm McDonal. Dramatic weight loss associated with commencing clozapine. BMJ case reports. vol 2011. 2013-08-26. PMID:22674113. |
the authors report the case of a 44-year-old man with a long history of chronic enduring schizophrenia who experienced dramatic weight loss after commencing treatment with clozapine, an antipsychotic medication characteristically associated with the greatest degree of weight gain among medical treatments for schizophrenia. |
2013-08-26 |
2023-08-12 |
Not clear |
| Tin-May Li, Chih-Tan Chung, I-Hua Wei, Chih-Chia Huan. Low-dose clozapine exacerbates and then improves mood in a patient with schizophrenia and history of surgical removal of an intraventricular meningioma. Journal of clinical psychopharmacology. vol 32. issue 6. 2013-08-26. PMID:23131888. |
low-dose clozapine exacerbates and then improves mood in a patient with schizophrenia and history of surgical removal of an intraventricular meningioma. |
2013-08-26 |
2023-08-12 |
Not clear |
| Chao-Cheng Lin, Hsien-Jane Chiu, Jen-Yeu Chen, Ying-Jay Liou, Ying-Chieh Wang, Tzu-Ting Chen, Ya-Mei Ba. Switching from clozapine to zotepine in patients with schizophrenia: a 12-week prospective, randomized, rater blind, and parallel study. Journal of clinical psychopharmacology. vol 33. issue 2. 2013-08-26. PMID:23422395. |
switching from clozapine to zotepine in patients with schizophrenia: a 12-week prospective, randomized, rater blind, and parallel study. |
2013-08-26 |
2023-08-12 |
Not clear |
| Chao-Cheng Lin, Hsien-Jane Chiu, Jen-Yeu Chen, Ying-Jay Liou, Ying-Chieh Wang, Tzu-Ting Chen, Ya-Mei Ba. Switching from clozapine to zotepine in patients with schizophrenia: a 12-week prospective, randomized, rater blind, and parallel study. Journal of clinical psychopharmacology. vol 33. issue 2. 2013-08-26. PMID:23422395. |
zotepine, an atypical antipsychotic with a pharmacologic profile similar to clozapine, was found to be an effective treatment for patients with treatment-resistant schizophrenia in japan. |
2013-08-26 |
2023-08-12 |
Not clear |
| R Gopalakrishnan, T P Subhalakshmi, A Kuruvilla, K S Jaco. Clozapine re-challenge under the cover of Filgrastim. Journal of postgraduate medicine. vol 59. issue 1. 2013-08-06. PMID:23525060. |
we report a case of a patient with treatment-resistant schizophrenia who developed neutropenia with clozapine as a result of which the drug was discontinued. |
2013-08-06 |
2023-08-12 |
Not clear |
| Gerhard Gross, Karsten Wicke, Karla U Dresche. Dopamine D₃ receptor antagonism--still a therapeutic option for the treatment of schizophrenia. Naunyn-Schmiedeberg's archives of pharmacology. vol 386. issue 2. 2013-07-30. PMID:23128852. |
despite considerable affinity for d(3) receptors, the second-generation antipsychotics clozapine, risperidone, and olanzapine when administered to patients with schizophrenia seem not to occupy d(3) receptors sufficiently to derive any conclusion on a d(3)-mediated therapeutic benefit. |
2013-07-30 |
2023-08-12 |
Not clear |
| Maryam Ravan, Duncan MacCrimmon, Gary Hasey, James P Reilly, Ahmad Khodayari-Rostamaba. A machine learning approach using P300 responses to investigate effect of clozapine therapy. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference. vol 2012. 2013-07-30. PMID:23367274. |
clozapine (clz) is uniquely effective as a treatment for medication resistant schizophrenia. |
2013-07-30 |
2023-08-12 |
human |
| Silvio Cacci. Safety and pharmacokinetics of atypical antipsychotics in children and adolescents. Paediatric drugs. vol 15. issue 3. 2013-07-30. PMID:23588704. |
recent controlled trials have demonstrated the efficacy of some of these agents (including aripiprazole, clozapine, olanzapine, paliperidone, quetiapine, risperidone, ziprasidone) in adolescent schizophrenia and children or adolescent bipolar mania, or to treat severe aggression and self-injury in the context of autism in children and adolescents. |
2013-07-30 |
2023-08-12 |
Not clear |
| N Y Lee, M S Roh, S H Kim, D C Jung, H Y Yu, K H Sung, I W Chung, T Youn, U G Kang, Y M Ahn, Y S Ki. The prevalence of metabolic syndrome and its association with alanine aminotransferase in clozapine-treated Korean patients with schizophrenia. International clinical psychopharmacology. vol 28. issue 2. 2013-07-12. PMID:23211493. |
we reviewed the electromedical records of patients with schizophrenia who had taken clozapine as the sole antipsychotic for 3 months or more. |
2013-07-12 |
2023-08-12 |
Not clear |
| N Y Lee, M S Roh, S H Kim, D C Jung, H Y Yu, K H Sung, I W Chung, T Youn, U G Kang, Y M Ahn, Y S Ki. The prevalence of metabolic syndrome and its association with alanine aminotransferase in clozapine-treated Korean patients with schizophrenia. International clinical psychopharmacology. vol 28. issue 2. 2013-07-12. PMID:23211493. |
korean patients with schizophrenia who were receiving clozapine as the sole antipsychotic showed a high prevalence of mets. |
2013-07-12 |
2023-08-12 |
Not clear |
| Paul Glue, Christopher Gale, David B Menkes, Noelyn Hun. Evaluation of bioequivalence between clozapine suspension and tablet formulations : a multiple-dose, fed and fasted study. Clinical drug investigation. vol 32. issue 11. 2013-07-11. PMID:23018283. |
clozapine is the most effective drug for schizophrenia. |
2013-07-11 |
2023-08-12 |
Not clear |
| Oliver Freudenreich, David C Henderson, Kathy M Sanders, Donald C Gof. Training in a clozapine clinic for psychiatry residents: a plea and suggestions for implementation. Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry. vol 37. issue 1. 2013-07-09. PMID:23338869. |
this matters because clozapine is an important evidence-based treatment for refractory schizophrenia that remains underutilized in clinical practice. |
2013-07-09 |
2023-08-12 |
Not clear |
| Joseph Martin Alisk. Cerebroventricular clozapine would be a viable treatment modality for clozapine-dependent schizophrenia patients with neutropenia. Medical hypotheses. vol 79. issue 4. 2013-07-08. PMID:22818272. |
cerebroventricular clozapine would be a viable treatment modality for clozapine-dependent schizophrenia patients with neutropenia. |
2013-07-08 |
2023-08-12 |
Not clear |
| Pradipta Majumder, R K Chadda, P Goyal, A Mittal, Nand Kuma. Clozapine induced eosinophilia. Indian journal of psychiatry. vol 53. issue 2. 2013-07-04. PMID:21772649. |
although there are reports of eosinophilia developing in course of treatment with clozapine among patients suffering from schizophrenia but this may be the first case of eosinophilia associated with clozapine use in case of schizoaffective disorder. |
2013-07-04 |
2023-08-12 |
Not clear |
| Alicia Hanes, Tammie Lee Demler, Claudia Lee, Alexander Campo. Pseudoephedrine for the treatment of clozapine-induced incontinence. Innovations in clinical neuroscience. vol 10. issue 4. 2013-07-04. PMID:23696957. |
clozapine, the first atypical antipsychotic, is well known for superior efficacy in the treatment of refractory schizophrenia. |
2013-07-04 |
2023-08-12 |
Not clear |
| Herbert Y Meltze. Update on typical and atypical antipsychotic drugs. Annual review of medicine. vol 64. 2013-07-02. PMID:23020880. |
clozapine is unique among the atypical apds in its efficacy for ameliorating psychosis in patients with treatment-resistant schizophrenia (trs), for reduction of suicide, and for improving longevity. |
2013-07-02 |
2023-08-12 |
Not clear |